- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03993444
Prevent Pain and Stress Related Sickleave. (PS)
September 20, 2022 updated by: Örebro University, Sweden
Problems with stress and pain are common reasons for long-term sick-leave, and need preventive interventions.
This RCT builds on a successful previous project (see reference section), where a program involving the work place, the individual and occupational health care resulted in decreased sick-leave and healthcare visits and a higher quality of life as compared to TAU for individuals with musculoskeletal pain.
This study will replicate and evaluate the mechanisms behind the involvement from the work place.
According to the transdiagnostic model, problems with stress and pain are maintained by similar processes.
Consequently, the study will be extended to include both problems, and it will be explored how a refined version of the program affects sick leave and work ability in the employees.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Compared to the earlier study, this RCT will include:
- A focused program targeting supervisors and employees
- An active control group
- An evaluation of the effects on both supervisor and employee
- Knowledge on the mechanisms involved
- Replication and extension of earlier findings
The project will produce knowledge about:
A procedure for identifying individuals at risk for sick-leave. The effects of a program targeting both workplace and individual to prevent problems with stress and pain.
The role of the supervisor in preventing sick-leave. Mechanisms linked to decreased levels of sick-leave.
Study Type
Interventional
Enrollment (Actual)
182
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Örebro, Sweden, 70182
- Center for Health and Medical Psychology (CHAMP) Örebro University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- participating employee has self rated symptoms of stress and/or pain and supervisor also partakes in intervention
- employed at a workplace within Regionhälsans (occupational health care center) uptake area
Exclusion Criteria:
- pain and/or stress symptoms due to medical conditions
- severe psychiatric conditions
- full time sick leave
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: communication and problem solving
Three smal group sessions (separate for employees (length 2 hours each) and for supervisors (length 2,5 hours each)) focused on training communication and problem solving skills.
|
a program for supervisors and employees including skills training, validating communication, problem solving
|
Active Comparator: psychoeducation
Two, 1 hour, lectures, one on the topic of pain and one on the topic of stress (for employees and supervisors combined).
|
lecture/course for supervisors and employees on risk factors and actions for people experiencing stress and/or pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
sick leave
Time Frame: 14 months
|
days on sick leave based on register data
|
14 months
|
sick leave
Time Frame: 8 months
|
days on sick leave based on self report
|
8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
stress symptoms
Time Frame: baseline, 2 months, 8 months
|
change in perceived stress scale-10, assessed in employees and supervisors
|
baseline, 2 months, 8 months
|
work ability
Time Frame: 2 months, 8 months
|
work ability index, assessed in employees and supervisors
|
2 months, 8 months
|
exhaustion symptoms
Time Frame: baseline, 2 months, 8 months
|
change in Karolinska Exhaustion Disorder Scale, assessed in employees and supervisors
|
baseline, 2 months, 8 months
|
pain problems
Time Frame: baseline, 2 months, 8 months
|
change in Örebro Musculoskeletal Pain Screening Questionaire, assessed in employees
|
baseline, 2 months, 8 months
|
work related factors
Time Frame: 2 months, 8 months
|
QPS nordic, assessed in employees and supervisors
|
2 months, 8 months
|
work limitations
Time Frame: 2 months, 8 months
|
Work Limitations Questionnaire, assessed in employees
|
2 months, 8 months
|
symptom catastrophizing
Time Frame: baseline, 2 months, 8 months
|
change in Symptom Catastrophizing Scale, assessed in employees
|
baseline, 2 months, 8 months
|
problem framing
Time Frame: baseline, 2 months, 8 months
|
change in Pain/stress Solutions questionnaire (PaSol), assessed in employees
|
baseline, 2 months, 8 months
|
communication
Time Frame: baseline, 2 months, 8 months
|
change in Validation Invalidation Response Scale, assessed in employees
|
baseline, 2 months, 8 months
|
life satisfaction
Time Frame: 2 months, 8 months
|
Brunnsviken Brief Quality of Life scale, assessed in employees and supervisors
|
2 months, 8 months
|
health
Time Frame: 2 months, 8 months
|
Visual Analogue Scale (0-100, higher values better health), assessed in employees and supervisors
|
2 months, 8 months
|
communication behavior
Time Frame: baseline, 2 months
|
change in Validating and Invalidating Behavior Coding Scale (VIBCS, two 0-7 scales, higher scores indicate higher levels of validating and invalidating communication)
|
baseline, 2 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
intervention credibility
Time Frame: baseline
|
participant perception of intervention credibility, one item taken from the Credibility and expectancy questionnaire
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: ida flink, PhD, Örebro University, Sweden
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Actual)
September 1, 2022
Study Completion (Actual)
September 1, 2022
Study Registration Dates
First Submitted
May 29, 2019
First Submitted That Met QC Criteria
June 19, 2019
First Posted (Actual)
June 20, 2019
Study Record Updates
Last Update Posted (Actual)
September 21, 2022
Last Update Submitted That Met QC Criteria
September 20, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MOT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
Clinical Trials on communication and problem solving
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Istanbul UniversityCompleted
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
University of OttawaOttawa Hospital Research InstituteActive, not recruiting
-
Washington University School of MedicineNurses for Newborns FoundationCompletedPost-partum DepressionUnited States
-
VA Office of Research and DevelopmentCompletedDepression | AnxietyUnited States
-
University of SheffieldUniversity of ManchesterCompleted
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedMild Cognitive ImpairmentUnited States
-
VA Office of Research and DevelopmentCompleted